[Pharmacokinetics of mitomycin C in cancer patients during prolonged administration of the preparation].
The mitomycin C levels in the blood of patients subjected to prolonged intravenous injection of the drug in 200-300 ml of isotonic sodium chloride solution for 15-50 minutes were determined in the microbiological test system consisting of E. coli and 1.5 per cent of agar in the meat-peptone broth with restricted contents of the nutrients. Such administration of the drug usually provided lower blood levels than intravenous injections of the drug in analogous doses. However, the drug renal excretion was also less intensive. It suggested that the drug administered for a prolonged period was more completely absorbed by the host tissues. This was confirmed by much lower blood levels of the drug, when the tumors were large, as compared to those in patients with insignificant residues of the tumor tissue after surgical resections. The curves of mitomycin C distribution in the blood indicate that the pharmacokinetics of the drug in patients with tumors is a multi-factorial function.
D001943:Breast Neoplasms / Q000628:therapy; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D007700:Kinetics; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage* / Q000097:blood / Q000652:urine; D009369:Neoplasms / Q000188:drug therapy*; D012004:Rectal Neoplasms / Q000628:therapy; D012811:Sigmoid Neoplasms / Q000628:therapy; D013274:Stomach Neoplasms / Q000628:therapy
D008937:Mitomycins; D016685:Mitomycin
Farmakokinetika mitomitsina C u rakovykh bol'nykh pri prolongirovannom vvedenii preparata.